Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2026-03-11 @ 4:01 PM
Study NCT ID:
NCT03871205
Status:
UNKNOWN
Last Update Posted:
2019-03-12
First Post:
2019-03-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer
Sponsor:
Shenzhen People's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ShenzhenPH BTR-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None